Real World and Genomic Data Based Asthma Insight Through Network Analysis
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Eileen Wang, MD
National Jewish Health
Principal Investigator - Ke Hao, PhD
Icahn School of Medicine at Mount Sinai
Principal Investigator - Linda Rogers, MD
Icahn School of Medicine at Mount Sinai
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- National Jewish Health
Denver, Colorado, United States
- Mount Sinai Beth Israel
New York, New York, United States
- Mount Sinai Hospital
New York, New York, United States
- Mount Sinai Morningside
New York, New York, United States
- Mount Sinai West
New York, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 Nov 2019
- Primary completion
- 16 Jun 2025
- Completion
- 16 Jun 2025
- Last update posted
- 18 Aug 2026
- Registered enrollment
- 1,075
- Registry id
- NCT06623435
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.